A comment on ion channels as pharmacological targets in oncology

Journal of General Physiology

Volumn 132, Issue 2, 2008, Pages 313-314

  Becchetti, Andrea ^a   Arcangeli, Annarosa ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; SHAKER POTASSIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TRANSCRIPTION FACTOR ERG;

CANCER THERAPY; CELL ADHESION; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; CHANNEL GATING; CONFORMATIONAL TRANSITION; LETTER; ONCOLOGY; PROTEIN PROTEIN INTERACTION; REPOLARIZATION;

ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; ION CHANNEL GATING; ION CHANNELS; NEOPLASMS; TECHNOLOGY, PHARMACEUTICAL;

EID: 48649099004     PISSN: 00221295     EISSN: 00221295     Source Type: Journal    
DOI: 10.1085/jgp.200810069     Document Type: Letter

References (16)

1. Andersen, O.S. 2008. Perspectives on how to drug an ion channel. J. Gen. Physiol. 131:395-397.
2. Arcangeli, A. 2005. Expression and role of hERG channels in cancer cells. Novartis Found. Syrup. 266:225-232.
3. Arcangeli, A., and A. Becchetti. 2006. Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol. 16:631-639.
4. + current. Proc. Biol. Sci. 248:235-240.
5. + channel β1 subunit-mediated neurite outgrowth requires Fyn kinase and contributes to postnatal CNS development in vivo. J. Neurosci. 28:3246-3256.
6. + channel in mouse early embryos. Nature. 365:560-562.
7. + channels in human T lymphocytes: a role in mi-togenesis? Nature. 307:465-468.
8. + channel in rat F-11 DRG cell line: pharmacological identification and biophysical characterization. J. Physiol. 496:13-23.
9. Gómez-Varela, D., E. Zwick-Wallasch, H. Knötgen, A. Sánchez, T. Hettmann, D. Ossipov, R. Weselah, C. Contreras-Jurado, M. Rothe, W. Stühmer, and L.A. Pardo. 2007. Monoclonal antibody blockade of the human Eagl potassium channel function exerts antitumor activity. Cancer Res. 67:7343-7349.
10. + channel. Proc. Natl. Acad. Sci. USA. 103:2886-2891.
11. Kaczorowski, G.J., O.B. McManus, B.T. Priest, and M.L. Garcia. 2008. Ion channels as drug targets: the next GPCRs. J. Gen. Physiol. 131:399-405.
12. Kunzelmann, K. 2005. Ion channels and cancer. J. Membr. Biol. 205:159-173.
13. + and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and β1 integrins. J. Exp. Med. 191:1167-1176.
14. + channel form a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood. 110:1238-1250.
15. Ransom, C.B., J.T. O'Neal, and H. Sontheimer. 2001. Volume-activated chloride channels contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci. 21:7674-7683.
16. Schwartz, M.A. 1993. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J. CellBiol. 120:1003-1010.